Cellcept



Indications and Reactions:

Role Indications Reactions
Primary
Renal Transplant 20.8%
Product Used For Unknown Indication 15.8%
Prophylaxis Against Transplant Rejection 13.8%
Drug Use For Unknown Indication 12.2%
Liver Transplant 4.8%
Systemic Lupus Erythematosus 4.2%
Prophylaxis Against Graft Versus Host Disease 4.1%
Hypertension 3.7%
Immunosuppression 3.2%
Transplant Rejection 2.1%
Heart Transplant 2.1%
Myasthenia Gravis 1.9%
Graft Versus Host Disease 1.8%
Prophylaxis 1.8%
Lupus Nephritis 1.6%
Infection Prophylaxis 1.5%
Nephrotic Syndrome 1.4%
Antifungal Prophylaxis 1.2%
Transplant 1.1%
Lung Transplant 0.8%
Death 35.7%
Transplant Rejection 17.5%
Vomiting 5.0%
White Blood Cell Count Decreased 4.3%
Kidney Transplant Rejection 3.4%
Cerebrovascular Accident 3.2%
Renal Failure 3.2%
Disease Progression 2.9%
Sepsis 2.8%
Thrombotic Microangiopathy 2.7%
Renal Impairment 2.6%
Pneumonia 2.5%
Weight Decreased 2.2%
Systemic Lupus Erythematosus 2.1%
Respiratory Failure 1.8%
Urinary Tract Infection 1.7%
Aplasia Pure Red Cell 1.6%
Diarrhoea 1.6%
Focal Segmental Glomerulosclerosis 1.6%
Myocardial Infarction 1.5%
Secondary
Renal Transplant 34.0%
Prophylaxis Against Transplant Rejection 11.5%
Drug Use For Unknown Indication 9.7%
Product Used For Unknown Indication 6.5%
Hypertension 5.2%
Prophylaxis 5.2%
Heart Transplant 4.8%
Immunosuppression 4.2%
Liver Transplant 3.4%
Systemic Lupus Erythematosus 2.7%
Lung Transplant 2.5%
Prophylaxis Against Graft Versus Host Disease 1.8%
Transplant Rejection 1.4%
Immunosuppressant Drug Therapy 1.3%
Cytomegalovirus Infection 1.2%
Infection Prophylaxis 1.1%
Diabetes Mellitus 1.0%
Behcet's Syndrome 0.9%
Bone Marrow Transplant 0.9%
Lupus Nephritis 0.8%
Vomiting 11.1%
White Blood Cell Count Decreased 10.4%
Urinary Tract Infection 6.9%
Pyrexia 6.7%
Renal Impairment 5.8%
Sepsis 5.5%
Neutropenia 5.1%
Renal Failure 5.1%
Transplant Rejection 5.1%
Thrombotic Microangiopathy 4.8%
Weight Decreased 4.5%
White Blood Cell Count Increased 4.3%
Thrombocytopenia 3.7%
Pneumonia 3.5%
Septic Shock 3.3%
Cytomegalovirus Infection 3.0%
Viral Infection 3.0%
Osteoporosis 2.8%
Diarrhoea 2.7%
Renal Failure Acute 2.6%
Concomitant
Product Used For Unknown Indication 29.0%
Renal Transplant 15.4%
Drug Use For Unknown Indication 12.3%
Prophylaxis Against Transplant Rejection 7.5%
Hypertension 4.9%
Immunosuppression 4.1%
Nuclear Magnetic Resonance Imaging 3.3%
Prophylaxis 3.3%
Liver Transplant 3.0%
Heart Transplant 2.9%
Pain 2.7%
Diabetes Mellitus 1.6%
Systemic Lupus Erythematosus 1.6%
Angiogram 1.5%
Lung Transplant 1.5%
Renal Failure Chronic 1.3%
Depression 1.1%
Pulmonary Arterial Hypertension 1.0%
Immunosuppressant Drug Therapy 1.0%
Anaemia 1.0%
Vomiting 12.2%
Death 8.7%
Pyrexia 6.5%
Weight Decreased 6.2%
Renal Failure Acute 5.3%
Transplant Rejection 5.3%
Therapeutic Response Decreased 5.1%
Kidney Transplant Rejection 4.9%
Thrombocytopenia 4.9%
Renal Failure 4.7%
White Blood Cell Count Decreased 4.5%
Pregnancy 4.3%
Sepsis 4.1%
Pneumonia 4.0%
Renal Impairment 4.0%
Drug Ineffective 3.3%
Urinary Tract Infection 3.3%
Skin Tightness 2.9%
Thrombotic Microangiopathy 2.9%
Weight Increased 2.9%
Interacting
Drug Use For Unknown Indication 25.4%
Prophylaxis Against Transplant Rejection 10.7%
Renal Transplant 8.5%
Pyrexia 7.9%
Hypertension 7.3%
Immunosuppressant Drug Therapy 6.8%
Immunosuppression 6.8%
Bone Marrow Conditioning Regimen 3.4%
Anxiety 2.8%
Depression 2.8%
Lung Transplant 2.8%
Dyspepsia 2.3%
Gastric Disorder 2.3%
Infection Prophylaxis 1.7%
Liver Transplant 1.7%
Prostate Cancer 1.7%
Renal Lymphocele 1.7%
Epstein-barr Virus Infection 1.1%
Gastritis 1.1%
Gout 1.1%
Drug Interaction 14.3%
Graft Versus Host Disease 14.3%
Wrong Technique In Drug Usage Process 11.9%
Fatigue 7.1%
White Blood Cell Count Decreased 7.1%
Sjogren's Syndrome 4.8%
Somnolence 4.8%
Staphylococcal Infection 4.8%
Tremor 4.8%
Delirium 2.4%
Haemoglobin Decreased 2.4%
Liver Disorder 2.4%
Pulmonary Tuberculosis 2.4%
Renal Failure Acute 2.4%
Renal Impairment 2.4%
Restlessness 2.4%
Splenomegaly 2.4%
Transplant Rejection 2.4%
Ventricular Extrasystoles 2.4%
Viral Infection 2.4%